Patent details

EP3607939 Title: PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR AND EMTRICITABINE

Basic Information

Publication number:
EP3607939
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP191992577
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR AND EMTRICITABINE
French Title of Invention:
FORMULATIONS PHARMACEUTIQUES COMPRENANT TENOFOVIR ET EMTRICITABINE
German Title of Invention:
PHARMAZEUTISCHE FORMULIERUNGEN BEINHALTEND TENOFOVIR UND EMTRICITABINE
SPC Number:

Dates

Filing date:
29/06/2016
Grant date:
01/06/2022
EP Publication Date:
12/02/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/06/2022
EP B1 Publication Date:
01/06/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/06/2022
Expiration date:
29/06/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/05/2022
 
 

Name:
Gilead Sciences, Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:
KOZIARA,, Joanna, M.
Address:
United States (US)

2

Name:
MCCALLISTER,, Scott
Address:
United States (US)

Priority

1

Priority Number:
201562187113 P
Priority Date:
30/06/2015
Priority Country:
United States (US)

2

Priority Number:
201662298373 P
Priority Date:
22/02/2016
Priority Country:
United States (US)

3

Priority Number:
201662301429 P
Priority Date:
29/02/2016
Priority Country:
United States (US)

4

Priority Number:
201662317286 P
Priority Date:
01/04/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/20; A61K 9/24; A61K 31/513; A61K 31/675; A61K 9/28; A61P 31/18; A61P 43/00; A61K 9/00;

Publication

European Patent Bulletin

1

Issue number:
202222
Publication date:
01/06/2022
Description:
Grant (B1)

2

Issue number:
202227
Publication date:
06/07/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages